iShares Biotechnology ETF (IBB) Holdings $134.19 +1.05 (+0.79%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$133.21 -0.98 (-0.73%) As of 03/14/2025 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipSEC FilingsShort InterestTrends Top 100 IBB HoldingsRankCompanyCurrent PriceWeightShares Held1GILDGilead Sciences$111.44-1.7%10.17%02AMGNAmgen$313.71+0.3%9.09%03VRTXVertex Pharmaceuticals$504.77+0.4%8.52%04REGNRegeneron Pharmaceuticals$666.87-2.0%7.35%05IQVIQVIA$185.40+2.2%3.32%06ALNYAlnylam Pharmaceuticals$241.76+0.0%3.00%07ARGXargenx$604.96+4.1%2.89%08MTDMettler-Toledo International$1,231.32+2.4%2.57%09WATWaters$378.18+3.8%2.19%010BNTXBioNTech$99.47+2.1%2.01%0 Get the Latest News and Ratings for IBB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 11BIIBBiogen$139.44-0.4%2.00%012NTRANatera$148.22+4.0%1.92%013ONCBeigene$259.19+1.8%1.70%014UTHRUnited Therapeutics$307.24+0.6%1.40%015ILMNIllumina$85.60+1.8%1.38%016INCYIncyte$67.86+0.2%1.37%017INSMInsmed$76.55+2.0%1.36%018BMRNBioMarin Pharmaceutical$69.44-1.6%1.29%019ITCIIntra-Cellular Therapies$131.26-0.1%1.26%020GMABGenmab A/S$20.51+2.8%1.17%021NBIXNeurocrine Biosciences$110.75+1.6%1.14%022MRNAModerna$34.62+0.9%1.05%023EXELExelixis$36.65-0.4%1.03%024TECHBio-Techne$62.16+3.8%0.95%025SRPTSarepta Therapeutics$97.19-1.2%0.91%026PCVXVaxcyte$74.37+1.8%0.88%027CRLCharles River Laboratories International$171.27+2.6%0.82%028MEDPMedpace$324.95+2.2%0.82%029RGENRepligen$150.62+5.7%0.81%030HALOHalozyme Therapeutics$62.27+2.0%0.72%031ASNDAscendis Pharma A/S$152.98+0.4%0.71%032MDGLMadrigal Pharmaceuticals$348.35+7.8%0.61%033BPMCBlueprint Medicines$89.58-0.3%0.55%034RVMDRevolution Medicines$39.12+0.2%0.54%035ALKSAlkermes$34.03+1.2%0.53%036CYTKCytokinetics$44.36-0.1%0.53%037LEGNLegend Biotech$37.20-2.2%0.52%038BBIOBridgeBio Pharma$32.97+2.0%0.50%039AXSMAxsome Therapeutics$121.91+0.2%0.49%040BRKRBruker$45.97+2.2%0.49%0Alert: DOGE goes live (Ad)Elon will most likely be at the helm of it all. And just days from now, could bring about the biggest economic transformation in American history. See, there's one particular part of Elon and Trump's plans that you need to pay special attention to right now.Click here to learn more.41IONSIonis Pharmaceuticals$32.96+0.2%0.45%042KRYSKrystal Biotech$179.38+1.1%0.42%043ROIVRoivant Sciences$10.66+2.3%0.39%044PTCTPTC Therapeutics$54.50+3.3%0.37%045VRNAVerona Pharma$61.39-6.1%0.36%046ADMAADMA Biologics$18.43+2.9%0.35%047CRSPCRISPR Therapeutics$42.12+0.3%0.35%048SWTXSpringWorks Therapeutics$51.14+2.8%0.35%049RAREUltragenyx Pharmaceutical$39.34+0.2%0.34%050BHVNBiohaven$29.24+3.6%0.32%051ACADACADIA Pharmaceuticals$17.50+4.3%0.31%052RNAAvidity Biosciences$31.11-3.2%0.31%053NUVLNuvalent$77.01+3.4%0.31%054ZLABZai Lab$38.20+5.7%0.29%055AKROAkero Therapeutics$44.15-1.6%0.28%056CRNXCrinetics Pharmaceuticals$34.47-1.6%0.28%057RYTMRhythm Pharmaceuticals$50.97+1.5%0.28%058XENEXenon Pharmaceuticals$35.32+0.4%0.28%059MRUSMerus$47.10-1.1%0.27%060TEMTempus AI$47.17+11.9%0.27%061FOLDAmicus Therapeutics$8.90+1.0%0.26%062APLSApellis Pharmaceuticals$24.66+1.2%0.26%063ACLXArcellx$71.68+0.1%0.25%064SRRKScholar Rock$34.60+0.1%0.25%065VCYTVeracyte$31.51+3.5%0.25%066VCELVericel$45.380.0%0.24%067DNLIDenali Therapeutics$15.15+1.7%0.23%068RXRXRecursion Pharmaceuticals$6.35+6.9%0.23%069ARWRArrowhead Pharmaceuticals$15.36+1.9%0.22%070TWSTTwist Bioscience$39.96+2.1%0.21%071PTGXProtagonist Therapeutics$54.78-0.2%0.20%072AGIOAgios Pharmaceuticals$30.93-0.5%0.19%073BEAMBeam Therapeutics$24.23-3.3%0.19%074SMMTSummit Therapeutics$20.79+8.3%0.19%075DVAXDynavax Technologies$13.87+1.3%0.18%076MIRMMirum Pharmaceuticals$44.28-0.6%0.18%077NVCRNovoCure$19.49-2.8%0.18%078TVTXTravere Therapeutics$19.73+3.1%0.18%079GRFSGrifols$7.98+3.4%0.17%080BCRXBioCryst Pharmaceuticals$7.70+2.1%0.16%081EWTXEdgewise Therapeutics$25.67+1.5%0.16%082KYMRKymera Therapeutics$34.37+2.8%0.16%083IDYAIDEAYA Biosciences$18.58-2.0%0.15%084JANXJanux Therapeutics$30.68-2.1%0.15%085MESOMesoblast$13.55+2.0%0.15%086MNKDMannKind$5.20+1.0%0.14%087TARSTarsus Pharmaceuticals$48.09+3.5%0.14%088VERAVera Therapeutics$27.99+1.2%0.14%089ARQTArcutis Biotherapeutics$14.62-1.3%0.13%090FTREFortrea$9.66+0.8%0.13%0A market crash is coming—here’s when (Ad)The stock market cycle I've used to identify the most likely day of the next market crash is the exact same indicator that helped me call the bear market of 2018... the bull market in 2020... the bear market in 2022... the roaring bull markets in 2023 and 2024... and more. I'm convinced it has helped me identify the next big crash too. We are at an important juncture in the markets. Knowing what to do in the months to come is critical.Click here to check out my full write-up.91GLPGGalapagos$26.01+0.1%0.13%092IOVAIovance Biotherapeutics$3.59+2.0%0.13%093OACBOaktree Acquisition Corp. II$9.380.12%094CGONCG Oncology$27.80+7.1%0.12%095IMVTImmunovant$19.52+3.9%0.12%096SNDXSyndax Pharmaceuticals$12.95-1.1%0.12%097WVEWave Life Sciences$10.22-0.5%0.12%098TXG10x Genomics$10.34+4.7%0.11%099ADPTAdaptive Biotechnologies$7.28+1.5%0.11%0100APGEApogee Therapeutics$39.94+4.2%0.11%0 Related Companies and Tools Related Companies PPH Holdings BBH Holdings PSCH Holdings PTH Holdings BIB Holdings LFSC Holdings IBBQ Holdings MEDX Holdings FTXH Holdings JDOC Holdings This page (NASDAQ:IBB) was last updated on 3/15/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.